About this journal
Aims and scope
RNA Biology is an open access international peer-reviewed journal for RNA research including structural biology, genome, transcription, and splicing research.
RNA has played a central role in all cellular processes since the beginning of life: decoding the genome, regulating gene expression, structural biology, mediating molecular interactions, and catalyzing chemical reactions.
RNA Biology, as a leading journal in the field, provides a platform for presenting and discussing all cutting-edge RNA research. The journal accepts the following types of article: Research Paper/Report, Brief Communications, Technical Paper, Commentaries and Views, Meeting Reports, Letters to the Editor, Reviews, Point-of-View, Commentaries.
The journal publishes research related to:
- RNA biochemistry & structural biology
- Transcription & translation
- Regulatory RNAs in eukaryotes and prokaryotes
- Sequencing & bioinformatics
- RNA localization
- RNA in disease and therapy
- other topics relevant to RNA biology
RNA Biology offers a variety of formats for paper submission, including original research articles, short reports, reviews and commentaries. The journal only publishes manuscripts in English.
Open Access means you can publish your research so it is free to access online as soon as it is published, meaning anyone can read (and cite) your work. Please see our guide to Open Access for more information. Many funders mandate publishing your research open access; you can check open access funder policies and mandates here. The standard article publishing charge (APC) for this journal is $3,175 / £2,495 / €2,895 / AUD 4,335 plus VAT, or other local taxes where applicable in your country. There is no submission charge. Find out more about article publishing charges and funding options.
RNA Biology operates a single anonymized peer review policy.
Read the Instructions for Authors .
Please note, from 2022 the Print ISSN is not in active use as this journal is no longer published in print.
*Please note that RNA Biology converted to a full Open Access journal from Volume 19 (2022).
Journal metrics
Usage
- 803K annual downloads/views
Citation metrics
- 3.6 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 4.5 (2023) 5 year IF
- 8.6 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 0.757 (2023) SNIP
- 1.510 (2023) SJR
Speed/acceptance
- 11 days avg. from submission to first decision
- 49 days avg. from submission to first post-review decision
- 13 days avg. from acceptance to online publication
- 29% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief
Alain Laederach
University of North Carolina, Chapel Hill
USA
Acquisitions Editor
Adam Weiss
Prague, CZ
[email protected]
Associate Editors
Rolf Backofen - Albert-Ludwigs-Universität, Freiburg, DE
Andrea Barta - Medical University of Vienna, Vienna, AT
Chunru Lin - MD Anderson Cancer Center, Houston, TX, US
Daniel Gautheret - Universitè Paris-Saclay, Gif sur Yvette, FR
Tony Gutschner - Martin Luther University, Halle, DE
Tetsuro Hirose - Osaka University, Suita, JP
Michael Jantsch - Medical University of Vienna, Vienna, AT
Marlene Oeffinger - Institut de recherches cliniques de Montréal, Montréal, CA
Kannanganattu V. Prasanth - University of Illinois at Urbana-Champaign, Urbana, IL, US
Andreas Keller - Saarland University, Saarbrücken, DE
Valérie de Crécy-Lagard - University of Florida, Gainesville, FL, US
Carol S. Lutz - Rutgers University, New Jersey, US
Gregory Matera - University of North Carolina, Chapel Hill, NC, US
Beatrix Suess - TU Darmstadt, Darmstadt, DE
Mithun Sinha - Indiana University, Indianapolis, US
Anita Marchfelder - Ulm University, Ulm, DE
Kai Papenfort - Friedrich Schiller University of Jena, Jena, DE
Xiangting Wang - University of Science & Technology of China, Hefei, CN
Editorial Board
Victor R. Ambros - Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, US
Benjamin Blencowe - University of Toronto, Toronto, ON, CA
Ronald R. Breaker - Yale University, New Haven, CT, US
Juergen Brosius - University of Münster, Münster, DE
Donald H. Burke - University of Missouri School of Medicine, Columbia, MO, US
Maria Carmo-Fonseca - University of Lisbon, Lisbon, PT
Ling-Ling Chen - Chinese Academy of Sciences, Shanghai, CN
Lesley J. Collins - Allan Wilson Centre for Molecular Ecology and Evolution, Palmerston North, NZ
Sven Diederichs - German Cancer Research Center, Heidelberg, DE
Witold Filipowicz - Friedrich Miescher Institute for Biomedical Research, Basel, CH
Elizabeth R. Gavis - Princeton University, Princeton, NJ, US
Paul P. Gardner - School of Biological Sciences, University of Canterbury, NZ
Kenn Gerdes - Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle, UK and Department of Biology, University of Copenhagen, Copenhagen, Denmark
Alexander Hüttenhofer - Section for Genomics and RNomics, Biocenter, Innsbruck Medical University, Innsbruck, AT
Jack D. Keene - Department of Molecular Genetics, Duke University Medical Center, Durham, NC, US
Tamas Kiss - Laboratoire de Biologie Moléculaire Eucaryote du CNRS, Toulouse, FR
Dagmar Klostermeier - Institute for Physical Chemistry, University of Muenster, Muenster, DE
Maria M. Konarska - The Rockefeller University, New York, NY, US
Ashish Lal - National Cancer Institute, NIH, Bethesda, MD, US
Lynne E. Maquat - University of Rochester, Rochester, NY, US
Manja Marz - Friedrich-Schiller-University of Jena, Jena, DE
Eric Moss - UMDNJ, Stratford, NJ, US
Karin Musier-Forsyth - The Ohio State University, Columbus, OH, US
Sathyanarayanan Puthanveettil - Department of Neuroscience, The Scripps Research Institute, FL, US Elena Rivas - HHMI Janelia Farm, Ashburn, VA, US
Pascale Romby - University of Strasbourg, Strasbourg, FR
Dieter Söll - Yale University, New Haven, CT, US
Haruhiko Siomi - Keio University, Tokyo, JP
Sunnie Thompson - The University of Alabama at Birmingham, Birmingham, AL, US
David Tollervey - University of Edinburgh, Edinburgh, UK
Jean-Jacques Toulme - Université Victor Segalen, Bordeaux, FR
Xiujie J. Wang - Institute of Genetics and Developmental Biology, CAS, Beijing, CN
Anton Wutz - ETH Zurich, Switzerland
Yungui Yang - Chinese Academy of Sciences, Beijing, CN
Michael Yarus - University of Colorado, Boulder, CO, US
Li Yiang - Fudan University, Shanghai, China
Shigeyuki Yokoyama - Department of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo, Tokyo, JP
Honorary Editor
Renée Schroeder
Max F. Perutz Laboratories, University of Vienna
Vienna, AT
Abstracting and indexing
RNA Biology is abstracted/indexed in:
- Adis International Ltd.
- Reactions Weekly (Online) - Chemical Abstracts Service
- Chemical Abstracts (Online) - EBSCOhost
- Biological Abstracts (Online) - Elsevier BV
- BIOBASE
- EMBASE
- Scopus- - DOAJ
- National Library of Medicine
- PubMed Central (PMC) - Thomson Reuters
- Biochemistry and Biophysics Citation Index (Online)
- Biological Abstracts (Online)
- BIOSIS Previews
- Science Citation Index Expanded
- Web of Science - U.S. National Library of Medicine
- MEDLINE
Open access
RNA Biology is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
News, offers and calls for papers
Continuous publication
Advertising information
Would you like to advertise in RNA Biology?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in RNA Biology.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors